Newspaper Advertisement for publication of Un-Audited Financial Results for the quarter and half year ended on September 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Daikaffil Chemicals India Ltd (Scrip Code: 530825) has published its unaudited financial results for the quarter and half year ended September 30, 2025 in The Free Press Journal (English) and Navshakti (Marathi) on November 15, 2025. The company reported zero revenue from operations across all reported periods. Standalone net loss after tax narrowed to ₹5.59 lakhs in Q2 FY26 from ₹9.45 lakhs in Q2 FY25, and to ₹15.04 lakhs for H1 FY26 versus ₹42.22 lakhs in H1 FY25. Basic and diluted EPS stood at ₹(0.04) for the quarter and ₹(0.10) for the half-year. Equity share capital is ₹1,456.22 lakhs with reserves of ₹6,044.53 lakhs. The board approved the results on November 14, 2025. The company manufactures OBA (optical brightening agents) and other chemicals under a single business segment. No consolidated results were prepared because its newly incorporated subsidiary, Mikusu Global Industries Limited, has not yet received its funding.
With zero operating revenue and recurring losses, the company shows no active commercial business in its core segment, which is a concern for shareholders. The narrowing of losses and the large positive swing in total comprehensive income to ₹285.01 lakhs (vs a ₹6,472.02 lakh loss in H1 FY25) suggest improvement, but shareholders should watch for actual revenue traction.